David Raben serves as Executive at Bicara Therapeutics Inc., where they oversee executive responsibilities. Since joining the company, David Raben has executed 9 insider transactions totaling $611.0K, demonstrating a bearish approach to their equity position. Their most recent transaction on Dec 26, 2025 involved exercising options for 19,789 shares valued at $75.0K.
David Raben currently holds 55,286 shares of Bicara Therapeutics Inc. (BCAX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, David Raben has been a net seller of BCAX stock. They have purchased $0 and sold $611.0K worth of shares.
David Raben's most recent insider trade was on Dec 26, 2025, when they sold 19,789 shares at $3.79 per share.
Get notified when new Form 4 filings are submitted
| $18.84 |
| Discretionary |
| Nov 25, 2025 | BCAX | $17.4K | Option Exercise | 4,594 | $3.79 | Discretionary |
| Nov 25, 2025 | BCAX | $17.1K | Sale | 906 | $18.84 | Discretionary |
| Nov 25, 2025 | BCAX | $3.4K | Option Exercise | 906 | $3.79 | Discretionary |
| Nov 24, 2025 | BCAX | $20.8K | Option Exercise | 5,500 | $3.79 | Discretionary |
| Nov 24, 2025 | BCAX | $101.5K | Sale | 5,500 | $18.45 | Discretionary |
| Oct 9, 2025 | BCAX | $405.9K | Sale | 22,000 | $18.45 | Discretionary |
| Oct 9, 2025 | BCAX | $83.4K | Option Exercise | 22,000 | $3.79 | Discretionary |